Abstract: The present application provides formulations of modified peripheral blood mononuclear cells (PBMCs), wherein the formulation comprises: PBMCs comprising at least one antigen (e.g., a human papillomavirus (HPV) antigen) and a cryopreservation medium. In some embodiments, the PBMCs are conditioned by incubating the PBMC in the presence of an adjuvant.

Abstract: A surfboard includes a board member for supporting a user and having two depressions formed in the rear portion and the upper portion of the board member and inclined rearwardly from a front end toward a rear end, and having a swelling formed between the depressions of the board member, and a performance enhancing device is formed in an outer side portion of each of the depressions of the board member for enhancing performance and higher directional control, increasing power when exiting a turn and the ability to hold its place higher upon the wave face, reducing sideslip, thereby allowing the board member to be effectively maneuvered or controlled by the user.